An agencywide inspections IT initiative and inspectorate restructuring undertaken to strengthen oversight of human food manufacturing also may improve the US Food and Drug Administration’s oversight of drugs and biologics manufacturing.
US FDA commissioner Robert Califf and deputy commissioner Janet Woodcock on 31 January announced plans to propose a restructuring not...





